SwanBio Therapeutics

United States
Bala Cynwyd, Pennsylvania, United States

Company profile

SwanBio Therapeutics company profile

SwanBio Therapeutics is a developer of a therapeutic technology designed to deliver dramatic clinical efficacy for the treatment of neurological diseases. The company's technology focuses on the development and commercialisation of genetically defined therapies for the treatment of neurological disorders.

Business identity

Contact email
[email protected]
Operating status
Closed
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2017-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
4
Total equity funding
$118M
Last funding
Series Unknown / $10M / 2023-10-04
Last equity funding
Series Unknown / $10M
Investors
3
Lead investors
2
Founders
3
Articles
13
Exited on
2024-06-17

Founders and investors

Founders

Florian EichlerKaren KozarskyRachel Salzman

Lead investors

Mass General Brigham VenturesSyncona Partners LLP

Investors

Mass General Brigham VenturesPartners Innovation FundSyncona Partners LLP